Literature DB >> 17550673

Quality of life in smokers: focus on functional limitations rather than on lung function?

Roeland Mm Geijer1, Alfred Pe Sachs, Theo Jm Verheij, Huib Am Kerstjens, Marijke M Kuyvenhoven, Arno W Hoes.   

Abstract

BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification of severity of chronic obstructive pulmonary disease (COPD) is based solely on obstruction and does not capture physical functioning. The hypothesis that the Medical Research Council (MRC) dyspnoea scale would correlate better with quality of life than the level of airflow limitation was examined. AIM: To study the associations between quality of life in smokers and limitations in physical functioning (MRC dyspnoea scale) and, quality of life and airflow limitation (GOLD COPD stages).
DESIGN: Cross-sectional study.
SETTING: The city of IJsselstein, a small town in the centre of The Netherlands.
METHOD: Male smokers aged 40-65 years without a prior diagnosis of COPD and enlisted with a general practice, participated in this study. Quality of life was assessed by means of a generic (SF-36) and a disease-specific, questionnaire (QOLRIQ).
RESULTS: A total of 395 subjects (mean age 55.4 years, pack years 27.1) performed adequate spirometry and completed the questionnaires. Limitations of physical functioning according to the MRC dyspnoea scale were found in 25.1% (99/395) of the participants and airflow limitation in 40.2% (159/395). The correlations of limitations of physical functioning with all quality-of-life components were stronger than the correlations of all quality-of-life subscales with the severity of airflow limitation.
CONCLUSION: In middle-aged smokers the correlation of limitations of physical functioning (MRC dyspnoea scale) with quality of life was stronger than the correlation of the severity of airflow limitation with quality of life. Future staging systems of severity of COPD should capture this and not rely on forced expiratory volume in one second (FEV1) alone.

Entities:  

Mesh:

Year:  2007        PMID: 17550673      PMCID: PMC2078172     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  28 in total

1.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update.

Authors:  L M Fabbri; S S Hurd
Journal:  Eur Respir J       Date:  2003-07       Impact factor: 16.671

2.  A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.

Authors:  T Hajiro; K Nishimura; M Tsukino; A Ikeda; T Oga; T Izumi
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Determinants of different dimensions of disease severity in asthma and COPD : pulmonary function and health-related quality of life.

Authors:  H A Wijnhoven; D M Kriegsman; A E Hesselink; B W Penninx; M de Haan
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

5.  Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.

Authors:  Roeland M M Geijer; Alfred P E Sachs; Theo J M Verheij; Philippe L Salomé; Jan-Willem J Lammers; Arno W Hoes
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

6.  Health-related quality of life in COPD: why both disease-specific and generic measures should be used.

Authors:  C P Engström; L O Persson; S Larsson; M Sullivan
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

7.  Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT).

Authors:  A Langhammer; R Johnsen; J Holmen; A Gulsvik; L Bjermer
Journal:  J Epidemiol Community Health       Date:  2000-12       Impact factor: 3.710

8.  Sex differences in lung vulnerability to tobacco smoking.

Authors:  A Langhammer; R Johnsen; A Gulsvik; T L Holmen; L Bjermer
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

Review 9.  The assessment of health status among patients with COPD.

Authors:  J R Curtis; D L Patrick
Journal:  Eur Respir J Suppl       Date:  2003-06

10.  Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire (QoLRIQ) in inpatient pulmonary rehabilitation.

Authors:  Henk F van Stel; A Rianne Maillé; Vivian T Colland; Walter Everaerd
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

View more
  3 in total

1.  Distance saturation product predicts health-related quality of life among sarcoidosis patients.

Authors:  Julie M Bourbonnais; Subramanian Malaisamy; Bhavinkumar D Dalal; Priyan C Samarakoon; Swapna R Parikh; Lobelia Samavati
Journal:  Health Qual Life Outcomes       Date:  2012-06-13       Impact factor: 3.186

2.  Cigarette and waterpipe smoking decrease respiratory quality of life in adults: results from a national cross-sectional study.

Authors:  Salamé Joseph; Salameh Pascale; Khayat Georges; Waked Mirna
Journal:  Pulm Med       Date:  2012-09-03

3.  Interaction of Depression and Nicotine Addiction on the Severity of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study.

Authors:  Peian Lou; Peipei Chen; Pan Zhang; Jiaxi Yu; Yong Wang; Na Chen; Lei Zhang; Hongmin Wu; Jing Zhao
Journal:  Iran J Public Health       Date:  2016-02       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.